Related references
Note: Only part of the references are listed.Genotype Driven Therapy for Non-Small Cell Lung Cancer: Resistance, Pan Inhibitors and Immunotherapy
Sitanshu S. Singh et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Targeting the PI3K/Akt/mTOR pathway in non-small cell lung cancer (NSCLC)
Aaron C. Tan
THORACIC CANCER (2020)
Extracellular vesicles in hematological malignancies
Zofia Litwinska et al.
LEUKEMIA & LYMPHOMA (2019)
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in rectal cancer patients following neoadjuvant chemoradiotherapy
Tae Gyu Kim et al.
TUMORI JOURNAL (2019)
Neutrophil-to-lymphocyte ratio as prognostic marker in esophageal cancer: a systematic review and meta-analysis
Giovanni Pirozzolo et al.
JOURNAL OF THORACIC DISEASE (2019)
Hypoxic Regulation of Neutrophils in Cancer
Daniel Triner et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Current Cancer Epidemiology
Camilla Mattiuzzi et al.
JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH (2019)
Development of a Risk Prediction Model and Clinical Risk Score for Isolated Tricuspid Valve Surgery
Damien J. LaPar et al.
ANNALS OF THORACIC SURGERY (2018)
Platelet microparticle delivered microRNA-Let-7a promotes the angiogenic switch
Chinedu Anene et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Platelets and extracellular vesicles in cancer: diagnostic and therapeutic implications
Melania Dovizio et al.
CANCER AND METASTASIS REVIEWS (2018)
Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with advanced non-small-cell lung cancer treated with nivolumab
Aya Nakaya et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2018)
Treatment of Advanced Non-Small Cell Luna Cancer in 2018
Deborah B. Doroshow et al.
JAMA ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Understanding the Multifaceted Role of Neutrophils in Cancer and Autoimmune Diseases
Xu Wang et al.
FRONTIERS IN IMMUNOLOGY (2018)
Procoagulant microparticles derived from cancer cells have determinant role in the hypercoagulable state associated with cancer
Aurelie Rousseau et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
Lesley Seymour et al.
LANCET ONCOLOGY (2017)
Extracellular vesicles as emerging targets in cancer: Recent development from bench to bedside
Kerui Wu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2017)
Circulating endothelial cells and microparticles for prediction of tumor progression and outcomes in advanced non-small cell lung cancer
Fadi Najjar et al.
CANCER BIOMARKERS (2017)
Angiogenic Microvascular Endothelial Cells Release Microparticles Rich in Tissue Factor That Promotes Postischemic Collateral Vessel Formation
Gemma Arderiu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Platelet microparticles: Detection and assessment of their paradoxical functional roles in disease and regenerative medicine
Thierry Burnouf et al.
BLOOD REVIEWS (2014)
On the origin of microparticles: From platelet dust to mediators of intercellular communication
Leslie A. Hargett et al.
PULMONARY CIRCULATION (2013)
Anti-Neutrophil Cytoplasmic Antibodies Stimulate Release of Neutrophil Microparticles
Ying Hong et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Involvement of platelet derived microparticles in tumor metastasis and tissue regeneration
David Varon et al.
THROMBOSIS RESEARCH (2012)
On the Trail of Microparticles
Nigel Mackman
CIRCULATION RESEARCH (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Platelet Microparticles: A Potential Predictive Factor of Survival in Hormone-Refractory Prostate Cancer Patients Treated with Docetaxel-Based Chemotherapy
Dominique Helley et al.
EUROPEAN UROLOGY (2009)
Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancer
S Kanazawa et al.
LUNG CANCER (2003)
Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor
HK Kim et al.
EUROPEAN JOURNAL OF CANCER (2003)
Share Paper
